MEPROLE 40mg/Vial price in UAE

Overview

Welcome to Dwaey, specifically on MEPROLE 40mg/Vial Lyophilized Powder for Injection page.
This medicine contains an important and useful components, as it consists of Omeprazole sodium 40 mg/Vial.
MEPROLE 40mg/Vial is available in the market in concentration 40 mg/Vial and in the form of Lyophilized Powder for Injection.

ANNORA PHARMA FZ-LLC is the producer of MEPROLE 40mg/Vial and it is imported from UAE, The most popular alternatives of MEPROLE 40mg/Vial are listed downward .

Mode Of Action

Omeprazole is a substituted benzimidazole gastric antisecretory agent and is also known as PPI. It blocks the final step in gastric acid secretion by specific inhibition of H+/K+ ATPase enzyme system present on the secretory surface of the gastric parietal cell. Both basal and stimulated acid are inhibited.

Indication

Peptic ulcer
H. pylori infection
Gastro-oesophageal reflux disease
Zollinger-Ellison syndrome
Oesophagitis
Acid-related dyspepsia
NSAID-associated ulceration

Precaution

Gastric malignancy should be ruled out. Pregnancy, lactation, childn <1 yr. Monitoring Parameters Monitor Mg concentrations prior to initiation and periodically thereafter. Lactation: Distributes into human breast milk; use caution

Side Effects

1-10% Headache (7%)
Abdominal pain (5%)
Diarrhea (4%)
Nausea (4%)
Vomiting (3%)
Flatulence (3%)
Dizziness (2%)
Upper respiratory infection (2%)
Acid regurgitation (2%)
Constipation (2%)
Rash (2%)
Cough (1%) Frequency Not Defined Fracture of bone
osteoporosis-related
Hepatotoxicity (rare)
Agranulocytosis
Anorexia
Gastric polyps
Hip fracture
Alopecia
Atrophic gastritis
Interstitial nephritis (rare)
Pancreatitis (rare)
Rhabdomyolysis
Taste perversion
Abnormal dreams
Toxic epidermal necrolysis (rare) Potentially Fatal: Anaphylaxis.

Contra indication

Known hypersensitivity to any of its component.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Increased risk of hypomagnesaemia w/ diuretics. May increase INR and prothrombin time w/ warfarin. Increased risk of digoxin-induced cardiotoxic effects. May increase plasma concentration benzodiazepines (e.g. diazepam), clarithromycin and methotrexate. Decreased absorption of itraconazole, ketoconazole, posaconazole, dasatinib, iron salts. May prolong elimination of diazepam, cilostazol, phenytoin and ciclosporin. May reduce the antiplatelet effect of clopidogrel. Potentially Fatal: May decrease plasma concentrations and pharmacological effects of rilpivirine, nelfinavir and atazanavir.